Flagship Founder and CEO Noubar Afeyan was joined by Aviv Regev, Executive Vice President at Genentech Research and Early Development (gRED) for a fascinating discussion on the intersection of AI and biology, the future of R&D, and the leaps in store for biomedicine. More from Flagship @ JPM2023 here.
More from:
Human Health
Three Questions with Junaid Bajwa, Flagship Senior Partner, Head of UK, and Science Partner for Pioneering Intelligence
The Future of Genetic Medicines is Here
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support
